Aprea Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aprea Therapeutics

12/08/2024 15:46

* Aprea Therapeutics Inc  APRE.OQ  reported a quarterly
adjusted
loss of 58 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -87 cents.  The mean expectation of
three analysts for the quarter was for a loss of 63 cents per
share. Wall Street expected results to range from -69 cents
to -58 cents per share.
    * Revenue rose 124.8% to $562.00 thousand from a year ago;
analysts expected $50.00 thousand. 
    * Aprea Therapeutics Inc's reported EPS for the quarter was
a loss
of 58 cents​.
    * The company reported a quarterly loss of $3.47 million.
    * Aprea Therapeutics Inc shares had fallen by 17.4% this
quarter and lost 28.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 21.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $16.00 
This summary was machine generated from LSEG data August 12 at
02:46 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.63          -0.58          Beat
 Mar. 31 2024      -0.78          -0.67          Beat
 Dec. 31 2023      -0.77          -0.92          Missed
 Sep. 30 2023      -1.16          -0.86          Beat